Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human

Lei Xia1, Xiaoyi Guo, Teli Liu

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China. zhuhuananjing@163.com pekyz@163.com.

Nanoscale
|July 24, 2019
PubMed

Insights

Researchers developed a novel nanoprobe for multimodal imaging of small-cell lung cancer (SCLC). This probe targets SCLC tumors expressing somatostatin receptor subtype 2 (SSTR2), enabling enhanced detection via photoacoustic imaging, MRI, and PET scans.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Pulmonary neuroendocrine tumors, including small-cell lung cancer (SCLC), represent a significant portion of lung cancer cases.
  • Somatostatin receptor subtype 2 (SSTR2) is highly expressed in SCLC, making it a potential therapeutic and diagnostic target.
  • Multimodal imaging agents are needed to provide comprehensive tumor integrity information for SCLC.

Purpose of the Study:

  • To construct a novel multifunctional nanoprobe for targeted multimodal imaging of SCLC.
  • To evaluate the efficacy of the developed nanoprobe in a preclinical SCLC model.

Main Methods:

  • Organic melanin nanoparticles (MNPs) were synthesized and surface-functionalized with octreotide, a somatostatin analog, creating OCT-PEG-MNPs.
  • MNPs were labeled with manganese (Mn2+) for magnetic resonance imaging (MRI) and iodine-124 (124I) for positron emission tomography (PET).
  • The multimodal imaging capabilities of the (124I, Mn) OCT-PEG-MNPs were assessed in an NCI-H69 SCLC tumor xenograft model with high SSTR2 expression.

Main Results:

  • The (124I, Mn) OCT-PEG-MNPs demonstrated effective multimodal imaging performance in photoacoustic imaging (PAI), MRI, and PET.
  • PAI showed increasing signal in the tumor site over time.
  • MRI revealed enhanced T1-weighted signal intensity in the xenograft 24 hours post-injection.
  • PET and biodistribution studies indicated significantly higher uptake in SCLC tumors compared to control models.

Conclusions:

  • The developed (124I, Mn) OCT-PEG-MNPs are effective for multimodal imaging of SCLC with high SSTR2 expression.
  • This nanoprobe integrates PAI, MRI, and PET capabilities, offering a promising tool for SCLC diagnosis and management.
  • The organic nanoparticle-based nanoprobe shows potential for future clinical translation.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.8K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.2K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
What is Natural Selection?01:32

What is Natural Selection?

Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.0K